94 filings
8-K
TNGX
Tango Therapeutics Inc
23 May 24
Tango Therapeutics Announces Discontinuation of TNG348 Program
7:18am
10-Q
2024 Q1
TNGX
Tango Therapeutics Inc
Quarterly report
8 May 24
7:21am
8-K
TNGX
Tango Therapeutics Inc
8 May 24
Tango Therapeutics Reports First Quarter 2024 Financial Results
7:14am
ARS
2023 FY
TNGX
Tango Therapeutics Inc
29 Apr 24
Annual report to shareholders
4:24pm
DEF 14A
TNGX
Tango Therapeutics Inc
Definitive proxy
29 Apr 24
4:17pm
PRE 14A
lhbom
17 Apr 24
Preliminary proxy
4:53pm
S-8
obqrh8anksk8x tq45
18 Mar 24
Registration of securities for employees
8:27am
8-K
0wk7ouu0
18 Mar 24
Tango Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
7:08am
8-K
qofdk ke6v1
7 Feb 24
Results of Operations and Financial Condition
7:00am
8-K
miucfh0frsnw0g
8 Nov 23
Tango Therapeutics Reports Third Quarter 2023 Financial Results
7:07am
EFFECT
lliyav9 bm0
12 Sep 23
Notice of effectiveness
12:15am
CORRESP
cfve312xkvhv8pgw
7 Sep 23
Correspondence with SEC
12:00am
UPLOAD
in2x09vu3gwgl8hjezsx
7 Sep 23
Letter from SEC
12:00am
8-K
gscfnydajzb 0i3
30 Aug 23
Departure of Directors or Certain Officers
6:04am
D
w7605
24 Aug 23
$80.02 mm in equity / options, sold $80.02 mm, 17 investors
4:10pm
8-K
96ipkr46n1f5cdv
10 Aug 23
Tango Therapeutics Announces $80 million Private Placement Financing
7:24am